NeoVista's Series D - II Round

NeoVista raised a round of funding on February 10, 2011.

NeoVista is developing medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). The company's technology utilizes highly targeted strontium 90 beta radiat…

Articles about NeoVista's Series D - II Round: